{"id":18580,"date":"2024-04-02T08:28:12","date_gmt":"2024-04-02T08:28:12","guid":{"rendered":"https:\/\/2023.re-check.ch\/?page_id=18580"},"modified":"2024-10-27T14:41:19","modified_gmt":"2024-10-27T14:41:19","slug":"oseltamivir-tamiflu","status":"publish","type":"page","link":"https:\/\/www.re-check.ch\/en\/projects\/oseltamivir-tamiflu\/","title":{"rendered":"Oseltamivir – Tamiflu"},"content":{"rendered":"\n
\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
\n

According to the best available evidence, this drug can shorten the symptoms of influenza-like illness by one and a half day. However, sales of Tamiflu\u00ae skyrocketed in 2005 with the blessing of the World Health Organisation, in the context of looming fears about a pandemic. How did a very expensive drug that is far from revolutionary become a blockbuster? <\/p>\n\n\n\n

The history of Tamiflu\u00ae is marked by conflicts of interest, \u201cbad science\u201d and the critical assessment by a group of scientists with the Cochrane Collaboration.<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n

Investigative documentary:<\/h2>\n\n\n\n
\n